bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.03.25.645280

A Software for Identification and Characterization of Theta Rhythms in the Hippocampus

Abstract

Characterizing theta rhythms in the hippocampus provides a window into understanding memory processing. An inquiry that arises when an animal sustains a pathological state is how theta rhythms are affected. In pathological states like epilepsy or Alzheimers, these rhythms change in specific ways. Statistically robust changes in these rhythms could serve as potential biomarkers, indicating the severity of the animals condition and the effectiveness of a drug. However, this understanding depends on how the data is analyzed. There are currently no standard criteria for recognizing theta dominance in experimental recordings. To address this, we have developed novel MATLAB-based software with an easy-to-use graphical user interface which enables identifying and analyzing theta rhythms in a standard way. We discuss the softwares functionality and its underlying algorithms. The algorithms were developed using previously acquired EEG/LFP data recorded from the hippocampus of a mouse kindling model of epilepsy. Two primary analyses were conducted to test the softwares functionality: first, comparing theta rhythms during the baseline period versus during spontaneous recurrent seizures; second, analyzing the timing of theta rhythms relative to the seizure event. Our illustrative results indicate that our developed software can robustly identify theta events with statistically significant feature differences. Further, the examination presented here with two mice shows that while theta events can occur just before seizures, it takes tens of minutes post-seizure before theta rhythms occur again. Our software thus provides the user with the ability to robustly identify and characterize theta rhythms and their feature changes. Significance StatementTheta rhythms in the hippocampus are fundamental for spatial navigation and memory formation. Their observed changes during several pathological states such as epilepsy and Alzheimers make them highly interesting to be able to serve as biomarkers. However, their variability (in terms of the time of occurrence, duration, and frequency range) makes them challenging to quantify. The absence of available tools for the automatic extraction of these rhythms from extended datasets significantly hampers processing efficiency and reduces accuracy and consistency. Clinicians and researchers often manually inspect their data to identify these rhythms, a process that is not only time-consuming but also inherently subjective. We have thus developed a MATLAB software for precise, automatic analysis of theta rhythms in EEG/LFP recordings.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bahador, N., Sengupta, S., Saha, J., Lankarany, M., Zhang, L., Skinner, F.. 2025-03-26. A Software for Identification and Characterization of Theta Rhythms in the Hippocampus. https://doi.org/10.1101/2025.03.25.645280

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗